Blood test registry aims to predict Cancer's return
NCT ID NCT02270567
Summary
This study is creating a registry to collect information and blood samples from 400 people with neuroendocrine tumors. The main goal is to see how well a specific blood test, called NETest, can help doctors detect the cancer early, monitor if it comes back, and predict how patients will respond to treatments. By tracking patients over time, researchers hope to learn if this test can improve care and outcomes for people with these tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wren Laboratories
Branford, Connecticut, 06405, United States
Conditions
Explore the condition pages connected to this study.